MonTa Biosciences
Manufacturing · Denmark · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Diplomvej 377, Kongens Lyngby, Capital R...Phone Number
+45 51186306Website
www.montabiosciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About MonTa Biosciences
MonTa Biosciences ApS is a clinical stage biotech company focused on developing innovative cancer treatments that leverage the immune system to target and eliminate tumor cells. Their lead product, MBS8, is a second-generation systemic TLR7 agonist aimed at converting cold tumors into hot ones, thereby enhancing the effectiveness of immunotherapy. The company has completed a Phase I safety study and is currently conducting an expansion study in checkpoint-resistant melanoma in Denmark and Spain. MonTa Biosciences is dedicated to improving patient outcomes by restoring anti-tumor immunity and building long-lasting immune memory.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MonTa Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on MonTa Biosciences recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once MonTa Biosciences has new funding data
Website visits: Recent activity has been detected on your website
Check out if MonTa Biosciences is spiking on competitors!
MonTa Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if MonTa Biosciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at MonTa Biosciences
Product Launch: Get notified when MonTa Biosciences launches new products
Check if MonTa Biosciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined MonTa Biosciences as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
MonTa Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
MonTa Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MonTa Biosciences.
MonTa Biosciences financials insights
Gather financial insights about MonTa Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Unspecified
$285K
MonTa Biosciences Tech Stack
A closer look at the technologies used by MonTa Biosciences
See more technologies
MonTa Biosciences News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MonTa Biosciences
Sign Up For FreeTo access detailed company insights
MonTa Biosciences ApS is a clinical stage biotech company focused on developing innovative cancer treatments that leverage the immune system to target and eliminate tumor cells. Their lead product, MBS8, is a second-generation systemic TLR7 agonist aimed at converting cold tumors into hot ones, thereby enhancing the effectiveness of immunotherapy.... Read More
